Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008-2024)
{{output}}
This systematic review evaluates psychiatric medications for schizophrenia approved between 2008 and 2024, considering regulatory practices and approvals across multiple regions, including the United States, Europe, and Asian countries. It details the mechanis... ...
